stars 1 stars 2 stars 3

A leading provider of pharmaceutical analysis and formulation support with 30+ years of experience in inhaled product development and Good Manufacturing Practice (GMP) compliant analytical testing and stability storage services. We have a reputation for providing outstanding and responsive customer service. Previously known as Melbourn Scientific Ltd, the laboratory, based near Cambridge UK, was acquired by Intertek in 2013. We opened a second facility in 2015 and another in 2019 leading to further expansion which has doubled our laboratory footprint. We have specialist skills and experience in analytical testing and formulation for inhaled and intranasal products as well as all other dosage forms for healthcare products. Clients include major pharmaceutical companies, drug delivery innovators, consultants and virtual companies. We have invested continually in the latest equipment and provides a range of services; pre-formulation and formulation, analytical support, method development and validation; stability studies and storage and accelerated feasibility studies. The laboratory is inspected and approved by the UK Medicines & Healthcare Products Regulatory Agency (MHRA) for GMP compliance. The Laboratory has also been inspected by the US Food and Drug Administration (FDA) against GMP as part of clients’ pre-approval inspections. Pharmaceutical Analytical Services Early Stage Pre-formulation support Formulation Development Orally Inhaled Product Development Inhalation Product Analysis And Testing Nasal Drug Product Development Analytical Method Development Method Validation Stability Storage and Testing Dissolution Testing Particle and Drop Characterization and Sizing Product Characterization Chemicals, Manufacturing and Controls (CMC) Support Clinical Trial GMP Manufacture QC Testing

Website http://www.intertek.com/pharmaceutical/melbourn/
Revenue $4.4 billion
Employees 107 (85 on RocketReach)
Founded 1989
Industry Pharmaceutical Manufacturing, Method development, Method Validation, Analytical support, Accelerated feasibility studies, Formulation, Product development, Raw material testing, QC and finished product testing, Inhaled product testing, Stability studies and storage
Web Rank 89148
Web Visits 548660
Keywords Pharmaceutical Analysis, Pharma Services, Cgmp, Drug Formulation, Analytical Testing Services, Drug Analysis, Pharmaceutical Quality, Inhalation Drug Delivery, Regulatory Compliance, Analytical Chemistry, Stability Studies, Quality Control Testing, Product Development, Contract Testing, Testing And Analysis, Quality Assurance
Competitors SGS, Bureau Veritas Group, Charles River Laboratories, Eurofins, WuXi AppTec, Covance, Pace® Labs, Labcorp, Stratpharma, MilliporeSigma +38 more (view full list)

Intertek Melbourn Questions

The Intertek Melbourn annual revenue was $4.4 billion in 2026.

Mark Parry is the Senior Scientific Director of Intertek Melbourn.

85 people are employed at Intertek Melbourn.

Top Intertek Melbourn Employees

Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users